Trial Profile
Clinical Trials Insight: 700031714
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Nov 2008
Price :
$35
*
At a glance
- Drugs TR 291144 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Trimeris
- 25 Oct 2008 Interim results reported at ICAAC/IDSA 2008.
- 08 Aug 2008 Top-line results reported in Trimeris media release.
- 08 Aug 2008 Status changed from recruiting to in progress according to Trimeris media release.